BlackRock Fund Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $5.88M | Buy |
565,440
+30,929
| +6% | +$321K | ﹤0.01% | 2856 |
|
2016
Q3 | $6.63M | Buy |
534,511
+23,647
| +5% | +$293K | ﹤0.01% | 2705 |
|
2016
Q2 | $5.49M | Sell |
510,864
-9,909
| -2% | -$106K | ﹤0.01% | 2743 |
|
2016
Q1 | $5.75M | Buy |
520,773
+59,911
| +13% | +$661K | ﹤0.01% | 2670 |
|
2015
Q4 | $5.63M | Sell |
460,862
-101,003
| -18% | -$1.23M | ﹤0.01% | 2780 |
|
2015
Q3 | $9.16M | Buy |
561,865
+53,956
| +11% | +$880K | ﹤0.01% | 2421 |
|
2015
Q2 | $10.8M | Buy |
507,909
+20,973
| +4% | +$444K | ﹤0.01% | 2456 |
|
2015
Q1 | $8.76M | Buy |
486,936
+44,171
| +10% | +$794K | ﹤0.01% | 2513 |
|
2014
Q4 | $7.59M | Buy |
+442,765
| New | +$7.59M | ﹤0.01% | 2625 |
|